Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase

AE Pegg, ME Dolan, RC Moschel - Progress in nucleic acid research and …, 1995 - Elsevier
Publisher Summary This chapter focuses on the structure and function of alkyltransferase
protein. O 6-alkylguanine-DNA alkyltransferase is a remarkable protein that alone can, in a …

Direct reversal of DNA alkylation damage

Y Mishina, EM Duguid, C He - Chemical reviews, 2006 - ACS Publications
Cellular DNA is constantly subjected to modifications by intracellular and extracellular
chemicals, which can result in covalent changes. 1, 2 Alkylating agents are one group of …

Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection …

ME Dolan, RC Moschel… - Proceedings of the …, 1990 - National Acad Sciences
O6-Alkylguanine-DNA alkyltransferase was rapidly and irreversibly inactivated by exposure
to O6-benzylguanine or the p-chlorobenzyl and p-methylbenzyl analogues. This inactivation …

A Critical Appraisal of the Evolution of N-Nitrosoureas as Anticancer Drugs

CT Gnewuch, G Sosnovsky - Chemical Reviews, 1997 - ACS Publications
The N-alkyl-and N-(2-haloethyl)-N-nitrosoureas represent one of the generally most useful
classes of anticancer agents, with a wide range of activities against various leukemias and …

Resistance to chemotherapy in cancer: a complex and integrated cellular response

HR Mellor, R Callaghan - Pharmacology, 2008 - karger.com
Inherent and acquired resistance pathways account for the high rate of failure in cancer
chemotherapy. The mechanisms or pathways mediating resistance may be classified as …

Targeting O 6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy

B Kaina, GP Margison, M Christmann - Cellular and Molecular Life …, 2010 - Springer
Abstract O 6-methylguanine-DNA methyltransferase (MGMT) repairs the cancer
chemotherapy-relevant DNA adducts, O 6-methylguanine and O 6-chloroethylguanine …

Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.

HS Friedman, DM Kokkinakis, J Pluda… - Journal of Clinical …, 1998 - ascopubs.org
PURPOSE The major mechanism of resistance to alkylnitrosourea therapy is the DNA repair
protein O6-alkylguanine-DNA alkyltransferase (AGT), which removes chlorethylation or …

Phase II Trial of Carmustine Plus O6-Benzylguanine for Patients With Nitrosourea-Resistant Recurrent or Progressive Malignant Glioma

JA Quinn, J Pluda, ME Dolan, S Delaney… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: We conducted a phase II trial of carmustine (BCNU) plus the O6-alkylguanine-
DNA alkyltransferase inhibitor O6-benzylguanine (O6-BG) to define the activity and toxicity …

Antitumour imidazotetrazines—XV: Role of guanine O6 alkylation in the mechanism of cytotoxicity of imidazotetrazinones

MJ Tisdale - Biochemical pharmacology, 1987 - Elsevier
Cell lines with constitutive levels of the DNA repair protein O 6-methylguanine-DNA
methyltransferase (O 6 MeGMT)(Mer+ phenotype) were less sensitive to the cytotoxic effects …

Improvement of chemotherapy efficacy by inactivation of a DNA-repair pathway

MR Middleton, GP Margison - The Lancet Oncology, 2003 - thelancet.com
Tumour resistance and dose-limiting toxic effects restrict treatment with most
chemotherapeutic drugs. Elucidation of the mechanisms of these effects could permit the …